Market Closed -
Nasdaq
04:00:00 2024-04-24 pm EDT
5-day change
1st Jan Change
906.5
USD
-0.09%
+0.59%
+3.22%
Sales 2024 *
13.89B
Sales 2025 *
14.85B
Capitalization
97.42B
Net income 2024 *
4.29B
Net income 2025 *
4.52B
EV / Sales 2024 *
6.39
x
Net cash position
2024
*
8.68B
Net cash position
2025
*
13.36B
EV / Sales 2025 *
5.66
x P/E ratio 2024 *
24.6
x
P/E ratio 2025 *
23.2
x
Employees
13,450
Yield 2024 *
-
Yield 2025 *
-
Free-Float
77.74%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Sanofi Q1 profit slips on generic competition, forex effects
01:30am
RE
TD Cowen Adjusts Regeneron Pharmaceuticals' Price Target to $1,030 From $1,020, Keeps Buy Rating
Apr. 24
MT
Unity Biotechnology Adds More Patients, Extends Length of Trial of Prospective Macular Edema Treatment
Apr. 23
MT
UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating
Apr. 17
MT
The market is pinning its hopes on earnings reports
Apr. 17
ANALYST RECOMMENDATIONS : Las Vegas Sands, Regeneron, Kinder Morgan, Rivian, Royal Caribbean...
Apr. 17
Regeneron to defend against DOJ complaint on drug-price manipulation
Apr. 15
RE
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
Apr. 15
RE
Goldman Sachs Adjusts Regeneron Pharmaceuticals Price Target to $1,126 From $1,121, Buy Rating Kept
Apr. 15
MT
Global markets live: Airbus, UBS, KKR, Meta Platforms, Tesla...
Apr. 11
Sector Update: Health Care Stocks Steady Pre-Bell Thursday
Apr. 11
MT
Will there be any Fed rate cuts this year?
Apr. 11
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge
Apr. 11
DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET
Apr. 11
DJ
News Highlights : Top Company News of the Day - Thursday at 3 AM ET
Apr. 11
DJ
More news
TD Cowen Adjusts Regeneron Pharmaceuticals' Price Target to $1,030 From $1,020, Keeps Buy Rating
Apr. 24
MT
UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating
Apr. 17
MT
ANALYST RECOMMENDATIONS : Las Vegas Sands, Regeneron, Kinder Morgan, Rivian, Royal Caribbean...
Apr. 17
Goldman Sachs Adjusts Regeneron Pharmaceuticals Price Target to $1,126 From $1,121, Buy Rating Kept
Apr. 15
MT
Morgan Stanley Raises Price Target on Regeneron Pharmaceuticals to $1,177 From $1,115, Keeps Overweight Rating
Apr. 09
MT
More recommendations
1 day +1.18%
1 week +0.59%
Current month -5.81%
1 month -6.28%
3 months -4.40%
6 months +12.71%
Current year +3.22%
More quotes
Managers
Title Age Since
Founder
64
88-01-07
Chief Executive Officer
71
88-01-07
Director of Finance/CFO
54
02-12-31
Members of the board
Title Age Since
Director/Board Member
71
10-11-11
Chief Executive Officer
71
88-01-07
Director/Board Member
82
91-05-31
More insiders
Date
Price
Change
Volume
24-04-24
906.5
-0.09%
373,718
24-04-23
907.3
+0.80%
341,220
24-04-22
900.2
+0.37%
351,366
24-04-19
896.8
+0.32%
507,466
24-04-18
894
-0.80%
450,630
Delayed Quote
Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes
Regeneron Pharmaceuticals, Inc. specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Net sales break down by type of revenue as follows:
- revenues from product sales (56.6%);
- revenues from collaboration agreements (40.4%): collaboration with Sanofi (58.1% of revenues), Bayer (29.1%) and Roche (12.8%);
- other (3%): primarily revenues from sales of technology licenses and subcontracted research services.
At the end of 2022, the group had a portfolio of approximately 35 products in clinical development.
More about the company
Last Close Price
906.5
USD
Average target price
1,036
USD
Spread / Average Target
+14.29%
Consensus
1st Jan change
Capi.
+3.22% 97.42B -1.51% 104B +1.80% 22.2B -16.53% 21.23B -9.10% 18.33B -42.33% 16.35B -20.09% 15.06B +5.47% 13.98B +28.85% 11.66B -24.93% 8.22B
Bio Therapeutic Drugs
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1